dihexa clinical trials or human studies or safety DH€XA & TE50 Dihexa (PNB-0408) — Dosing, Side

Peptides, 3(6), 623626

4A, B, Supplemental Fig

03 Research Highlights Cellular studies demonstrate increased lipolysis and fatty acid oxidation in differentiated adipocytes Animal models show reduced diet-induced obesity and improved insulin sensitivity with NNMT inhibition NAD+ metabolomics studies confirm restoration of cellular NAD+ and SAMe pools following NNMT blockade 04 Dosage Administration & Timing Oral administration (capsule or solution) or Subcutaneous (SC) injection into abdominal or gluteal subcutaneous tissue

Ornoy et al., 2015)

The key is choosing safe, complementary treatments rather than simply stacking multiple interventions without guidance